These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6203227)

  • 1. [Combined use of interferon inducers and recombinant influenza viruses for protection from the disease].
    Podcherniaeva RIa; Shchipanova MV; Nosik NN; Ershov FI; L'vov DK
    Vopr Virusol; 1984; 29(2):173-5. PubMed ID: 6203227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunization with a complex preparation: a new method of influenza prevention. The basis for using a complex preparation for preventing influenza].
    Shvartsman IaS; Ispolatova AV; Tsybul'skaia NV; Shapiro NI; Aksenov OA
    Vopr Virusol; 1982; 27(2):142-6. PubMed ID: 6178215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanisms of the formation of heterologous resistance in peroral immunization with a complex anti-influenza preparation].
    Markevich NA; Maslennikova II; Pokrovskaia EE; Osipova MV; Ispolatova AV
    Vestn Ross Akad Med Nauk; 1996; (1):51-4. PubMed ID: 8907427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cross protection in mice immunized with different anti-influenza preparations].
    Rudenko LG; Sosunov AV; Zykov MP
    Vopr Virusol; 1981; (6):706-9. PubMed ID: 7336695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of interferon inducers in experimental influenza].
    Ershov FI; Moshchik KV
    Vopr Virusol; 1984; 29(6):706-7. PubMed ID: 6084899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of antibodies and interferon in resistance in influenza virus at early periods of immunization].
    Kosiakov PN; Rovnova ZI; Isaeva EI
    Vopr Virusol; 1973; 18(2):172-5. PubMed ID: 4705386
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunostimulating effect of interferon inducers].
    Ershov FI; Barinskiĭ IF; Podcherniaeva RIa; Gribencha SV; Popova OM
    Vopr Virusol; 1983; 28(4):74-9. PubMed ID: 6195825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
    Delem A
    Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon-inducing and protective action of polyguacyl in an experimental influenza infection].
    Obrosova-Serova NP; Fomina AN; Slepushkin AN; Grushinskaia IA; Balashov VI
    Vopr Virusol; 1981; (4):423-8. PubMed ID: 6171099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenic properties of epidemic and recombinant strains of influenza viruses H1N1 and H3N2].
    Shchipanova MV; Podcherniaeva RIa; Blinova VK
    Vopr Virusol; 1984; 29(3):273-6. PubMed ID: 6464424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increased effectiveness of influenza prevention vaccination by using levamisole].
    Pavlishin VV; Savtsova ZD; Giulling EV
    Vopr Virusol; 1984; 29(2):248-50. PubMed ID: 6730442
    [No Abstract]   [Full Text] [Related]  

  • 12. A one-size-fits-all flu vaccine?
    Kaiser J
    Science; 2006 Apr; 312(5772):380-2. PubMed ID: 16627732
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimization of the schemes for using interferon inducers].
    Ershov FI; Moshchik KV; Grigorian SS; Fomina AN
    Antibiotiki; 1982 Apr; 27(4):280-4. PubMed ID: 6178364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
    Polezhaev FI; Budilovskiĭ GN; Garmashova LM; Romeĭko-Gurko IuR; Egorov AIu
    Vopr Virusol; 1983; 28(6):710-4. PubMed ID: 6670253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interferon-inducing and anti-influenzal properties of 3-(2,2,2-trimethylhydrazine)propionate in an experiment].
    Kremerman IB; Priĭmiagi LS; Kal'vin'sh IIa; Lukevits EIa
    Vopr Virusol; 1987; 32(5):576-9. PubMed ID: 2448958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of the prophylactic anti-influenza and interferon-inducing activity of epsilon-aminocaproic acid].
    Kremerman IB; Priĭmiagi LS; Lozitskiĭ VP; Tefanova VT
    Antibiot Khimioter; 1988 Jan; 33(1):63-7. PubMed ID: 2454085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the immunological and protective effect in the simultaneous and separate use of live and killed influenza vaccines].
    Orlov VA; Zhilova GP; Smorodintsev AA; Kozhukhov VM; Ignat'eva GS
    Vopr Virusol; 1985; 30(3):280-5. PubMed ID: 4049837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunomodulating action of levamisole in its combined use with influenza vaccines].
    Obrosova-Serova NP; Schastnyĭ EI; Kupriashina LM; Slepushkin AN; Shenderovich SF
    Vopr Virusol; 1984; 29(4):454-9. PubMed ID: 6208690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.